Undifferentiated carcinoma metastatic to the bowel is uncommon in surgical pathology practice and might be confused with primary gastrointestinal carcinoma, melanoma, lymphoma, and others. We present 14 cases of uni- (n = 9) or multifocal (n = 5) undifferentiated large cell/rhabdoid carcinoma presenting in the bowel of patients with concurrent (n = 9) or recent (diagnosed 1 to 25 months earlier; median, 4) non-small cell lung cancer (NSCLC). Patients were 6 females and 8 males, aged 52 to 85 years. Primary NSCLC was verified histologically in 10 cases and by imaging in 4. The undifferentiated histology was present in the lung biopsy in 4/10 patients (as sole pattern in 3 and combined with adenocarcinoma in 1) and was limited to the intestinal metastases in the remainder. PDL1 was strongly expressed in 7/9 cases (CPS: 41 to 100). Loss of at least one SWI/SNF subunit was detected in 7/13 cases (54%). SMARCA2 loss (n = 6) was most frequent and was combined with SMARCA4 loss in one case. PBRM1 loss was observed in one tumor. Successful molecular testing of 11 cases revealed BRAF mutations in 4 (3 were non-V600E variants), KRAS mutations in 3, and wildtype in 4. None had EGFR mutations. Analysis of 4 paired samples revealed concordant KRAS (2) and BRAF (1) mutations or wildtype (1). Our study indicates that undifferentiated carcinoma within the intestines of patients with concurrent/recent NSCLC represents dedifferentiated metastasis from the NSCLC. Recognition of this unusual presentation is cardinal to avoid misdiagnosis with inappropriate therapeutic and prognostic implications.

Department of General Visceral and Transplantation Surgery University of Heidelberg Heidelberg Germany

Department of Pathology Faculty of Medicine in Pilsen Charles University Prague Czech Republic

Department of Pathology H Lee Moffitt Cancer Center and Research Institute and Departments of Pathology and Cell Biology and Oncologic Sciences University of South Florida Tampa FL USA

Institute of Pathology Friedrich Alexander University Erlangen Nürnberg University Hospital Erlangen Erlangen Germany

Zobrazit více v PubMed

WHO Classification of Tumours of the Digestive System . 5th. Lyon: IARC Press; 2019.

Bak M, Teglbjaerg PS. Pleomorphic (giant cell) carcinoma of the intestine. An immunohistochemical and electron microscopic study. Cancer. 1989;64:2557–2564. doi: 10.1002/1097-0142(19891215)64:12<2557::AID-CNCR2820641225>3.0.CO;2-G. PubMed DOI

Agaimy A, Rau TT, Hartmann A, Stoehr R. SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review. Am J Surg Pathol. 2014;38:910–920. doi: 10.1097/PAS.0000000000000173. PubMed DOI

Agaimy A, Daum O, Märkl B, Lichtmannegger I, Michal M, Hartmann A. SWI/SNF complex-deficient undifferentiated/rhabdoid carcinomas of the gastrointestinal tract: a series of 13 cases highlighting mutually exclusive loss of SMARCA4 and SMARCA2 and frequent co-inactivation of SMARCB1 and SMARCA2. Am J Surg Pathol. 2016;40:544–553. doi: 10.1097/PAS.0000000000000554. PubMed DOI

Agaimy A, Specht K, Stoehr R, Lorey T, Märkl B, Niedobitek G, Straub M, Hager T, Reis AC, Schilling B, Schneider-Stock R, Hartmann A, Mentzel T. Metastatic malignant melanoma with complete loss of differentiation markers (undifferentiated/dedifferentiated melanoma): analysis of 14 patients emphasizing phenotypic plasticity and the value of molecular testing as surrogate diagnostic marker. Am J Surg Pathol. 2016;40:181–191. doi: 10.1097/PAS.0000000000000527. PubMed DOI

Agaimy A, Stoehr R, Hornung A, Popp J, Erdmann M, Heinzerling L, Hartmann A (2021) Dedifferentiated and undifferentiated melanoma: report of 35 new cases with literature review and proposal of diagnostic criteria. Am J Surg Pathol 45:240–254 PubMed

Washington K, McDonagh D. Secondary tumors of the gastrointestinal tract: surgical pathologic findings and comparison with autopsy survey. Mod Pathol. 1995;8:427–433. PubMed

Burbige EJ, Radigan JJ, Belber JP. Metastatic lung carcinoma involving the gastrointestinal tract. Am J Gastroenterol. 1980;74:504–506. PubMed

Antler AS, Ough Y, Pitchumoni CS, Cavidian M, Thelmo W. Gastrointestinal metastases form malignant tumors of the lung. Cancer. 1982;49:70–2.7. doi: 10.1002/1097-0142(19820101)49:1<170::AID-CNCR2820490134>3.0.CO;2-A. PubMed DOI

McNeill PM, Wagman LD, Neifeld JP. Small bowel metastases from primary carcinoma of the lung. Cancer. 1987;59:1486–1489. doi: 10.1002/1097-0142(19870415)59:8<1486::AID-CNCR2820590815>3.0.CO;2-W. PubMed DOI

Berger A, Cellier C, Daniel C, Kron C, Riquet M, Barbier JP, Cugnenc PH, Landi B. Small bowel metastases from primary carcinoma of the lung: clinical findings and outcome. Am J Gastroenterol. 1999;94:1884–1887. doi: 10.1111/j.1572-0241.1999.01224.x. PubMed DOI

Chen J. Undiagnosed primary lung carcinoma with initial manifestation of intestinal obstruction: a case report and literature review. J Cancer Res Ther. 2015;11(Suppl 1):C134–C137. doi: 10.4103/0973-1482.163873. PubMed DOI

Hillenbrand A, Sträter J, Henne-Bruns D. Frequency, symptoms and outcome of intestinal metastases of bronchopulmonary cancer. Case report and review of the literature. Int Semin Surg Oncol. 2005;2:13. doi: 10.1186/1477-7800-2-13. PubMed DOI PMC

Phillips DL, Benner KG, Keeffe EB, Traweek ST. Isolated metastasis to small bowel from anaplastic thyroid carcinoma. With a review of extra-abdominal malignancies that spread to the bowel. J Clin Gastroenterol. 1987;9:563–567. doi: 10.1097/00004836-198710000-00017. PubMed DOI

Rossi G, Marchioni A, Romagnani E, Bertolini F, Longo L, Cavazza A, Barbieri F. Primary lung cancer presenting with gastrointestinal tract involvement: clinicopathologic and immunohistochemical features in a series of 18 consecutive cases. J Thorac Oncol. 2007;2:115–120. doi: 10.1016/S1556-0864(15)30037-X. PubMed DOI

Sheikh SS, Al-Khatti AA, Amr SS. Metachronus malignant rhabdoid tumor of the ileum and adenocarcinoma of lung: a unique case report. Ann Diagn Pathol. 2008;12:57–61. doi: 10.1016/j.anndiagpath.2006.06.007. PubMed DOI

Otera H, Ikeda F, Nakagawa S, Kono Y, Sakurai T, Tada K, Hashimoto K, Ikeda A. Intussusception of small intestine due to metastasis of large cell carcinoma of the lung with a rhabdoid phenotype. Eur Respir Rev. 2010;19:248–252. doi: 10.1183/09059180.00001610. PubMed DOI PMC

Koh H, Chiyotani A, Tokuda T, Suzumura H, Kamiishi N, Takahashi H, Hirose S. Pleomorphic carcinoma showing rapid growth, multiple metastases, and intestinal perforation. Ann Thorac Cardiovasc Surg. 2014;20(Suppl):669–673. doi: 10.5761/atcs.cr.13-00167. PubMed DOI

Hara S, Hosoi K, Suga Y, Takata T, Degami H, Kinoshita Y, Min K. Multiple cytokines-producing pleomorphic carcinoma of lung with metastasis to the small intestine. Ann Thorac Cardiovasc Surg. 2014;20(Suppl):666–668. doi: 10.5761/atcs.cr.13-00202. PubMed DOI

Herpel E, Rieker RJ, Dienemann H, Muley T, Meister M, Hartmann A, Warth A, Agaimy A. SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens. Ann Diagn Pathol. 2017;26:47–51. doi: 10.1016/j.anndiagpath.2016.10.006. PubMed DOI

Zhou H, Liu J, Zhang Y, Huang Y, Shen J, Yang Y, Fang W, Zhang L. PBRM1 mutation and preliminary response to immune checkpoint blockade treatment in non-small cell lung cancer. NPJ Precis Oncol. 2020;4:6. doi: 10.1038/s41698-020-0112-3. PubMed DOI PMC

Kadoch C, Crabtree GR. Mammalian SWI/SNF chromatin remodeling complexes and cancer: mechanistic insights gained from human genomics. Sci Adv. 2015;1(5):e1500447. doi: 10.1126/sciadv.1500447. PubMed DOI PMC

Alrabadi N, Gibson N, Curless K, Cheng L, Kuhar M, Chen S, Warren SJP, Alomari AK. Detection of driver mutations in BRAF can aid in diagnosis and early treatment of dedifferentiated metastatic melanoma. Mod Pathol. 2019;32:330–337. doi: 10.1038/s41379-018-0161-0. PubMed DOI

Lindberg M, Boström M, Elliott K, Larsson E. Intragenomic variability and extended sequence patterns in the mutational signature of ultraviolet light. Proc Natl Acad Sci U S A. 2019;116:20411–20417. doi: 10.1073/pnas.1909021116. PubMed DOI PMC

Sun L, Cliften PF, Duncavage EJ, Lewis JS, Jr, Chernock RD. UV signature mutations reclassify salivary high-grade neuroendocrine carcinomas as occult metastatic cutaneous merkel cell carcinomas. Am J Surg Pathol. 2019;43:682–687. doi: 10.1097/PAS.0000000000001231. PubMed DOI

Yang C, Sanchez-Vega F, Chang JC, Chatila WK, Shoushtari AN, Ladanyi M, Travis WD, Busam KJ, Rekhtman N. Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma. Mod Pathol. 2020;33:2244–2255. doi: 10.1038/s41379-020-0594-0. PubMed DOI PMC

Hanson JA, Trent JC, Yang D, Cooper K. Small-intestinal rhabdoid gastrointestinal stromal tumor (GIST): mutation analysis and clinical implications of a rare morphological variant. Int J Surg Pathol. 2011;19:653–657. doi: 10.1177/1066896911404413. PubMed DOI

Cao Q, Liu F, Li S, Liu N, Li L, Li C, Peng T. Primary rare anaplastic large cell lymphoma, ALK positive in small intestine: case report and review of the literature. Diagn Pathol. 2016;11:83. doi: 10.1186/s13000-016-0539-6. PubMed DOI PMC

Mariño-Enríquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD, Coffin CM, Hornick JL. Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol. 2011;35:135–144. doi: 10.1097/PAS.0b013e318200cfd5. PubMed DOI